Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap

Impact of diabetes on COVID‐19 and other infection: Report from the 22nd Hong Kong Diabetes and Cardiovascular Risk Factors—East Meets West Symposium

(2021) Andrea O. Y. Luk et al.   DIABETIC MEDICINE

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective

(2021) Ibrahim M. Ibrahim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

(2021) Jochem B Buil et al.   Eurosurveillance

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

(2021) Paul E. Verweij et al.   INTENSIVE CARE MEDICINE

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

(2021) Valliappan Muthu et al.   MYCOPATHOLOGIA

COVID‐19‐associated mucormycosis: An updated systematic review of literature

(2021) Rimesh Pal et al.   MYCOSES

Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study

(2021) Valliappan Muthu et al.   MYCOSES

Mucormycosis in CAPA, a Possible Fungal Super-Infection

(2021) Paola Saltini et al.   Journal of Fungi

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

(2020) Philipp Koehler et al.   LANCET INFECTIOUS DISEASES

Correlation of fungal cultures from non-sterile sites and Galactomannan assay with the diagnosis of aspergillosis and mucormycosis based on sterile culture results and histopathologic findings

(2019) Taeeun Kim et al.   Infectious Diseases

A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

(2019) A. Patel et al.   CLINICAL MICROBIOLOGY AND INFECTION

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents

(2016) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION